Literature DB >> 18453791

Ten years and counting: the journal of clinical hypertension.

Marvin Moser.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18453791      PMCID： PMC8109946          DOI： 10.1111/j.1751-7176.2008.08085.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  57 in total

1.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

Review 2.  Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Authors:  Lars Hjalmar Lindholm; Bo Carlberg; Ola Samuelsson
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

3.  Prehypertension--what is it and should it be treated?

Authors:  Marvin Moser; Thomas D Giles; Joseph L Izzo; Henry R Black
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

4.  Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.

Authors:  Clive Rosendorff; Henry R Black; Christopher P Cannon; Bernard J Gersh; Joel Gore; Joseph L Izzo; Norman M Kaplan; Christopher M O'Connor; Patrick T O'Gara; Suzanne Oparil
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

5.  Inadequate management of blood pressure in a hypertensive population.

Authors:  D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

6.  Lifestyle Changes That Reduce Blood Pressure: Implementation in Clinical Practice.

Authors:  Edgar R. Miller; Thomas P. Erlinger; Deborah R. Young; Greg P. Prokopowicz; Lawrence J. Appel
Journal:  J Clin Hypertens (Greenwich)       Date:  1999-11       Impact factor: 3.738

7.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

Authors:  T W Gress; F J Nieto; E Shahar; M R Wofford; F L Brancati
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

8.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

Review 9.  Hypertension in the elderly: a review of the importance of systolic blood pressure elevation.

Authors:  Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Mar-Apr       Impact factor: 3.738

10.  At the tipping point: accomplishing population-wide sodium reduction in the United States.

Authors:  Lawrence J Appel
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.